Vaccines: Active Or Passive Immunity?

Vaccines are complex biological products that contain one or more antigens, which stimulate an active immune response. The immune system can be divided into two main subsystems: the innate/general resistance system and the adaptive system. The first arm of the adaptive immune system is humoral immunity, which functions against extracellular pathogenic agents and toxins. Active immunity is long-lasting and sometimes life-long, and it occurs when exposure to a disease organism triggers the immune system to produce antibodies to that disease. Passive immunity, on the other hand, is the direct transfer of antibodies to a non-immune person to provide temporary protection. This type of immunity is provided by antibodies produced by another human being or animal.

Characteristics of Active and Passive Humoral Immunity

Active immunity is long-lasting, and can sometimes be life-long

Active immunity is a type of immunity that is produced when the immune system is exposed to a disease-causing organism, triggering it to produce antibodies to that disease. This can be achieved through natural immunity or vaccine-induced immunity. In the latter case, vaccines work by imitating an infection, introducing a disease-causing organism into the body to engage the body's natural defences. The active ingredient in all vaccines is an antigen, which causes the immune system to begin producing antibodies.

Active immunity is long-lasting and can sometimes be life-long. This is in contrast to passive immunity, which is temporary and usually lasts only a few weeks or months. Passive immunity occurs when a person is given antibodies to a disease rather than producing them through their own immune system. Passive immunity provides immediate protection, whereas active immunity takes time to develop, usually several weeks.

The length of protection provided by active immunity depends on the type of vaccine. Live-attenuated vaccines, which contain living bacteria or viruses, can provide enduring protection with only two doses. On the other hand, non-live vaccines typically require at least three doses to achieve protection and may require booster doses to maintain protection over time.

Active immunity can also be acquired by surviving an infection with the disease-causing organism. In general, once a person recovers from an infectious disease, they will have lifelong immunity to that disease, although there are exceptions, such as malaria. This long-lasting protection is known as immunologic memory. Upon re-exposure to the antigen, memory B-cells in the blood and bone marrow begin to replicate and produce antibodies rapidly to re-establish protection.

Passive immunity is temporary, and is provided by antibodies produced by another human or animal

Passive immunity is a short-term form of immunity that is achieved through the transfer of antibodies to a disease, rather than the production of antibodies by one's own immune system. It is often used when there is a need for immediate protection from a specific disease. Passive immunity is usually temporary and can be provided by antibodies produced by another human or animal.

In the case of humans, passive immunity is commonly transferred from mother to child. During pregnancy, antibodies and pathogen-fighting white cells are transferred from the mother to the developing child, especially in the third trimester. After birth, a substance called colostrum, which is produced by the mother during nursing sessions before the production of breast milk, is rich in antibodies and provides protection for the infant. Breast milk also contains antibodies that pass to the nursing infant, although not as concentrated as those in colostrum. Maternal antibody levels in the infant gradually decrease over the first few months of life, and the protection fades by about six months of age.

Passive immunity can also be artificially induced when antibodies are given as a medication to a non-immune individual. These antibodies may come from the pooled and purified blood products of immune humans or from non-human sources, such as animals. For example, antibody-containing blood products from immunized animals have been used to treat diseases such as diphtheria in humans. Additionally, bovine immunoglobulin preparations against rotavirus and E. coli have been used in farm animals and have shown therapeutic effects against gastrointestinal pathogens in humans.

The main advantage of passive immunity is that it provides immediate protection, whereas active immunity takes several weeks to develop. However, passive immunity is temporary and does not lead to the formation of long-lasting memory immune cells. Furthermore, in the case of antibodies harvested from animals, there is a risk of serious allergic reactions in the recipient.

Active immunity is produced by a person's own immune system

Active immunity is a type of immunity where the body's immune system is stimulated to produce antibodies against disease-causing organisms. This is in contrast to passive immunity, where pre-formed antibodies are transferred to an individual, providing temporary protection. Active immunity can be acquired through natural exposure to a disease-causing organism or through vaccination.

Vaccines work by imitating an infection, introducing a disease-causing organism into the body to trigger its natural defences. The active ingredient in vaccines is an antigen, which causes the immune system to begin producing antibodies. These antibodies are proteins produced by white blood cells, also known as B-cells, to identify and neutralize foreign substances. B-cells are produced in the bone marrow and then travel to the lymph nodes, where they mature and are exposed to pathogenic agents.

Upon exposure to an antigen, B-cells can recognize and bind to specific pathogens or toxins, leading to the production of antibodies. This is known as humoral immunity, which is a critical aspect of the adaptive immune system. The adaptive immune system works in conjunction with the innate immune system to provide an effective immune response against pathogenic agents.

Vaccines can induce both humoral immunity and cellular immunity, also known as T-cell-mediated immunity. While humoral immunity relies on antibodies produced by B-cells, cellular immunity involves the activation of T-cells. These T-cells can be either CD4 cells or CD8 cells, and they play a crucial role in fighting infections and generating memory cells for future protection.

Active immunity acquired through vaccination usually takes around 10 to 14 days to develop and can provide long-lasting protection, sometimes even lifelong. This is in contrast to passive immunity, which provides immediate protection but typically lasts only a few weeks or months.

Passive immunity is the direct transfer of antibodies to a non-immune person

Passive immunity occurs when preformed antibodies are transferred to an unimmunized individual. This individual then develops temporary immunity to a particular organism or toxin due to the presence of these preformed antibodies. Passive immunity is provided by antibodies produced by another human being or animal. For example, full-term babies acquire passive immunity from their mother's antibodies during the final months of pregnancy. This type of immunity is also called '"humoral immunity".

Passive immunity provides immediate protection but only lasts for a few weeks or months. It can be achieved through antibody-containing blood products derived from human or animal sources, such as immune globulin. Specific immunoglobulins can protect against diseases such as hepatitis B, rabies, tetanus, and diphtheria. Passive immunisation can also use normal human immunoglobulin as pre- or post-exposure prophylaxis against hepatitis A and measles.

Passive immunity is often used when immediate protection from a specific disease is required. For example, immunoglobulins can interfere with the response to some live attenuated viral vaccines, so it is important to leave an interval between administering immunoglobulins and certain vaccines.

Active immunity can be acquired through natural immunity or vaccine-induced immunity

Active immunity is when exposure to a disease triggers the immune system to produce antibodies to fight that disease. Active immunity can be acquired through natural immunity or vaccine-induced immunity.

Natural immunity is acquired when someone is exposed to a disease organism through infection with the actual disease. For example, natural immunity is gained after someone has had COVID-19. This form of immunity may be short-term or lifelong. In the case of COVID-19, natural immunity lessens over time. People with weakened immune systems may not build up effective natural immunity after an infection.

Vaccine-induced immunity is acquired through the introduction of a killed or weakened form of a disease organism through vaccination. Vaccines contain antigens, which are substances that cause the immune system to begin producing antibodies. The number of doses needed to achieve immunity depends on whether the antigen in a vaccine is alive or not. Live-attenuated vaccines can provide enduring protection with only two doses. Non-live vaccines typically require at least three doses to achieve protection and must be restored with booster doses.

Both natural immunity and vaccine-induced immunity are forms of active immunization. In both cases, the immune system creates antibodies and T-cells, but they are triggered by different substances. Germs from an infection prompt the body to develop natural immunity, whereas substances in vaccines, like weakened microbes or proteins, create vaccine-induced immunity.

Active immunity takes several weeks to develop, but it is long-lasting and sometimes life-long. Passive immunity, on the other hand, provides immediate protection but lasts only a few weeks or months.

Frequently asked questions